# Associations Between Cannabis Use and Inflammatory Biomarkers Among People with HIV. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-inflammatory-biomarkers-hiv-patients-study/ > **Published:** 2026-04-27T18:26:54-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:02:05-04:00 > **Clinical Summary:** New research examines associations between cannabis use and inflammatory biomarkers in people with HIV on antiretroviral therapy with viral suppression. --- CED Clinical Relevance  #72Notable Clinical Interest Evidence Brief | CED ClinicCurrent [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) was associated with lower inflammatory biomarkers in people with HIV who achieved viral suppression on antiretroviral therapy. HivInflammationBiomarkersObservational Study[Immune Function](https://cedclinic.com/circadian-medicine-cannabis-immune-timing/) Current [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) was associated with lower inflammatory biomarkers in people with HIV who achieved viral suppression on antiretroviral therapy. What This Study Teaches Us This cross-sectional analysis suggests current cannabis use may correlate with reduced systemic inflammation in virally suppressed people with HIV. The study provides observational evidence that cannabis use patterns differ in their association with inflammatory markers in this population. Why This Matters People with HIV experience persistent immune activation despite effective antiretroviral therapy, contributing to accelerated aging and comorbidities. If cannabis genuinely modulates inflammation in this context, it could inform discussions about potential benefits and risks of cannabis use in HIV care. Study Snapshot Study Type Cross-sectional Cohort Analysis Population 532 people with HIV on antiretroviral therapy with viral suppression Intervention Self-reported cannabis use categorized as Never, Former, or Current (past 3 months) Comparator Never users and former users Primary Outcome Thirteen plasma inflammatory biomarkers measured once Key Finding Current cannabis use associated with lower inflammatory biomarker levels compared to never/former use Journal Cannabis and [Cannabinoid Research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) Year 2024 Clinical Bottom Line Among virally suppressed people with HIV, current cannabis users showed lower inflammatory biomarkers than non-users. This observational finding requires replication and mechanistic validation before informing clinical recommendations. What This Paper Does Not Show This study cannot establish causation between cannabis use and reduced inflammation. It does not demonstrate clinical benefits, optimal dosing, [delivery methods](https://cedclinic.com/state-ban-smokable-cannabis-impact-central-texas/), or long-term outcomes. The findings may not apply to people with detectable viral loads or different HIV disease stages. Where This Paper Deserves Skepticism Cross-sectional design prevents causal inference. Unmeasured confounders could explain the association – healthier individuals might be more likely to use cannabis. Self-reported cannabis use lacks standardization for dose, frequency, or cannabinoid content. Single biomarker measurements may not reflect chronic inflammatory status. Dr. Caplan's Take I see this as hypothesis-generating rather than practice-changing. The anti-inflammatory properties of cannabinoids are biologically plausible, but observational associations in complex populations like people with HIV require careful interpretation. I would not recommend cannabis specifically for inflammation management in HIV patients based on this study alone. What a Careful Reader Should Take Away Current cannabis users with suppressed HIV showed lower inflammatory markers in this observational study. While mechanistically interesting, this single cross-sectional analysis cannot establish cannabis as an anti-inflammatory intervention. Clinical decisions should await prospective controlled studies. Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Associations%20Between%20Cannabis%20Use%20and%20Inflammatory%20Biomarkers%20Among%20People%20with%20HIV.%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Fcannabis-inflammatory-biomarkers-hiv-patients-study%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabis-inflammatory-biomarkers-hiv-patients-study%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Associations%20Between%20Cannabis%20Use%20and%20Inflammatory%20Biomarkers%20Among%20People%20with%20HIV.%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Fcannabis-inflammatory-biomarkers-hiv-patients-study%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Table of Contents - [FAQ](#FAQ)[Does cannabis use affect inflammation in people with HIV?](#Does_cannabis_use_affect_inflammation_in_people_with_HIV) - [Is cannabis safe for HIV patients on antiretroviral therapy?](#Is_cannabis_safe_for_HIV_patients_on_antiretroviral_therapy) - [How was cannabis use measured in this study?](#How_was_cannabis_use_measured_in_this_study) - [What inflammatory biomarkers were affected by cannabis use?](#What_inflammatory_biomarkers_were_affected_by_cannabis_use) - [Can these findings guide clinical recommendations for HIV patients?](#Can_these_findings_guide_clinical_recommendations_for_HIV_patients) - [Related](#Related) ## FAQ #### Does cannabis use affect inflammation in people with HIV? This study found that current cannabis use was associated with lower inflammatory biomarkers in people with HIV who achieved viral suppression on antiretroviral therapy. The research examined 13 plasma biomarkers among 532 participants and suggests cannabis may have [anti-inflammatory effects](https://cedclinic.com/cbd-antioxidative-anti-inflammatory-properties-benefits/) in this population. #### Is cannabis safe for HIV patients on antiretroviral therapy? The study focused on participants who were virally suppressed on antiretroviral therapy and found associations with reduced inflammation markers. However, this observational study cannot establish causation or comprehensive safety, and patients should discuss cannabis use with their HIV care providers to evaluate individual risks and benefits. #### How was cannabis use measured in this study? Cannabis use was categorized as Never, Former, or Current (past 3-month) use based on self-reported data collected within 1 year prior to biomarker collection. The study specifically examined current use patterns rather than dosing, frequency, or method of consumption. #### What inflammatory biomarkers were affected by cannabis use? The study measured 13 plasma inflammatory biomarkers, though the specific biomarkers and magnitude of reduction are not detailed in the available summary. The biomarkers were log-transformed and standardized to allow for comparison across different inflammatory markers. #### Can these findings guide clinical recommendations for HIV patients? While the association between cannabis use and lower inflammation is notable, this observational study cannot establish causation or clinical benefit. Healthcare providers should consider this emerging evidence alongside other factors when discussing cannabis use with HIV patients, particularly those with chronic inflammation concerns. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).